Ignite Creation Date:
2025-12-25 @ 1:44 AM
Ignite Modification Date:
2026-01-05 @ 1:51 AM
Study NCT ID:
NCT04213794
Status:
TERMINATED
Last Update Posted:
2025-02-20
First Post:
2019-12-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients
Sponsor:
Mayo Clinic
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Malignant Abdominal Neoplasm | View |
| None | Malignant Pelvic Neoplasm | View |
| None | Recurrent Colon Carcinoma | View |
| None | Recurrent Desmoplastic Small Round Cell Tumor | View |
| None | Recurrent Fallopian Tube Carcinoma | View |
| None | Recurrent Gastric Carcinoma | View |
| None | Recurrent Liposarcoma | View |
| None | Recurrent Malignant Mesothelioma | View |
| None | Recurrent Ovarian Carcinoma | View |
| None | Recurrent Primary Peritoneal Carcinoma | View |
| None | Recurrent Rectal Carcinoma | View |
| None | Recurrent Rhabdomyosarcoma | View |
| None | Recurrent Sarcoma | View |
| None | Refractory Colon Carcinoma | View |
| None | Refractory Desmoplastic Small Round Cell Tumor | View |
| None | Refractory Fallopian Tube Carcinoma | View |
| None | Refractory Gastric Carcinoma | View |
| None | Refractory Liposarcoma | View |
| None | Refractory Malignant Mesothelioma | View |
| None | Refractory Ovarian Carcinoma | View |
| None | Refractory Primary Peritoneal Carcinoma | View |
| None | Refractory Rectal Carcinoma | View |
| None | Refractory Rhabdomyosarcoma | View |
| None | Refractory Sarcoma | View |
| None | Resectable Liposarcoma | View |
| None | Resectable Malignant Mesothelioma | View |
| None | Resectable Sarcoma | View |
Keywords: